Tech Company Financing Transactions
Arintra Funding Round
Arintra, based in Austin, received $21 million from Peak XV Partners, Counterpart Ventures and Spider Capital.
Transaction Overview
Company Name
Announced On
8/13/2025
Transaction Type
Venture Equity
Amount
$21,000,000
Round
Series A
Investors
Proceeds Purpose
The proceeds will be used to expand adoption across U.S. health systems and physician groups, accelerate product development, scale its team, and open a new Bay Area headquarters.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
5900 Balcones Drive 4253
Austin, TX 78731
USA
Austin, TX 78731
USA
Phone
Website
Email Address
Overview
Arintra provides the industry's leading GenAI-native autonomous coding platform, enabling health systems to get paid accurately and efficiently for the care they deliver, driving revenue assurance at scale. By combining cutting-edge AI with deep clinical expertise, Arintra autonomously codes charts with high accuracy, without human intervention. Unlike bolt-on tools, Arintra works directly within the EHR, ensuring seamless adoption with zero workflow changes or data integrity risk. Health systems use Arintra to unlock missed revenue due to coding gaps, documentation issues, and unchallenged denials - achieving 5%+ uplift in revenue, 12%+ reduction in A/R days, and 43%+ fewer denials.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Founder
Preeti Bhargava
Founder
Nitesh Shroff
Browse more venture capital transactions:
Prev: 8/13/2025: Neuralzome Cybernetics venture capital transaction
Next: 8/13/2025: Conformal Medical venture capital transaction
Share this article
News on VC Transactions
We do our best to document all VC transactions involving tech companies. VC investment data records reported here are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs